stockrowTakeda Pharmaceutical Co.
TAK Healthcare Drug Manufacturers Specialty & Generic
Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.
- Revenue
- +1.71%
- EPS
- −4.35%
- Free cash flow
- +54.9%
- Total debt
- −7.28%
Quarter to September 2026, against a year earlier
Follow TAK
Alert me
Takeda Pharmaceutical Co. (TAK) Gross margin
Takeda Pharmaceutical Co.'s gross margin over the twelve months to 30 June 2026 was 65.9%, up 0.7 percentage points from fiscal 2026 (65.1%). Over the past ten years it has ranged from 65.1% (fiscal 2026) to 131.1% (fiscal 2021) — the current reading is the lowest in ten years. That is above the Drug Manufacturers Specialty & Generic industry median of 53.5% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 65.1% | (0.39) |
| FY2025 | 65.5% | (1.03) |
| FY2024 | 66.5% | (2.57) |
| FY2023 | 69.1% | 0.12 |
| FY2022 | 69.0% | (62.10) |
| FY2021 | 131.1% | 64.20 |
| FY2020 | 66.9% | (1.65) |
| FY2019 | 68.5% | (3.45) |
| FY2018 | 72.0% | 4.25 |
| FY2017 | 67.7% | (2.64) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 66.7% | 1.42 |
| Jun 2025 | 65.2% | (2.73) |
| Jun 2024 | 68.0% | 4.70 |
| Mar 2024 | 63.3% | (2.58) |
| 25 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| UTHR United Therapeutics Corporation compare | 86.3% |
| ZTS Zoetis Inc. compare | 71.7% |
| TAK Takeda Pharmaceutical Co. | 65.9% |
| HLN Haleon PLC Sponsored ADR compare | 62.2% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| TEVA Teva Pharmaceutical Industries Ltd. compare | 53.5% |
| RDY Dr. Reddy's Laboratories Ltd compare | 49.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on TAK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement